Enovis (ENOV) FCF Payout Ratio (2012 - 2013)

Enovis' (ENOV) quarterly FCF Payout Ratio came in at 0.11 in Q3 2013, up 1598430.39% quarter-over-quarter from 0.0 in Q4 2012.

Analysis

Enovis (ENOV) FCF Payout Ratio (2012 - 2013) Analysis & Trends

Enovis (ENOV) has reported FCF Payout Ratio for 2 consecutive years, with 0.11 the latest figure, recorded in Q3 2013.

On a quarterly basis, FCF Payout Ratio changed N/A year-over-year to 0.11 in Q3 2013; TTM through Dec 2013 was 0.03, a 89.55% decrease from a year earlier, with the FY2019 full-year figure at 16.86, changed N/A from the prior year.
FCF Payout Ratio was 0.11 for Q3 2013 at Enovis, up from 0.0 in the prior quarter.
Over five years, FCF Payout Ratio peaked at 0.49 in Q2 2012 and troughed at 0.02 in Q1 2012.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Cover (Qtr)
1	Abbott Laboratories	182.70 Bn	177.10 Bn	7.27 Bn	0.55
2	Intuitive Surgical	126.56 Bn	121.34 Bn	1.96 Bn	-
3	Medtronic	118.15 Bn	109.33 Bn	6.34 Bn	0.71
4	Stryker	104.94 Bn	101.46 Bn	4.50 Bn	0.32
5	Boston Scientific	64.79 Bn	64.25 Bn	3.85 Bn	-
6	Edwards Lifesciences	49.87 Bn	45.62 Bn	1.35 Bn	-
7	Alcon	33.04 Bn	31.59 Bn	1.68 Bn	-
8	Dexcom	32.07 Bn	30.13 Bn	830.00 Mn	-
9	Steris	20.78 Bn	20.29 Bn	684.20 Mn	0.22
10	Enovis	1.08 Bn	1.07 Bn	359.25 Mn	-

Historic Data

Download Data